Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Solutex is a global biotechnology company specializing in the development and manufacture of high-purity omega-3 fatty acids and specialized lipid mediators. The company is widely recognized for its Omegatex brand, which provides ultra-pure EPA and DHA concentrates for the pharmaceutical, nutraceutical, and functional food industries. Utilizing proprietary green chemistry technologies, including Supercritical Fluid Extraction (SFE) and Chromatography (SFC), Solutex produces ingredients with exceptional purity and concentration levels. A key innovation is their Lipinova platform, which focuses on Pro-Resolving Mediators (PRMs) to address chronic inflammation. Headquartered in Spain with a global distribution network, Solutex offers comprehensive services from raw material sourcing to finished product manufacturing, supporting therapeutic areas such as cardiovascular health, ophthalmology, and neurology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Omegatex.